Q&A

Q&A
Q&A
03/24/2023
In this Q&A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
03/24/2023
Expert Q&A
Expert Q&A
03/23/2023
In this Q&A, Manuel Castillo-Angeles, MD, MPH, postdoctoral research fellow at the Center for Surgery and Public Health, Brigham and Women’s Hospital discusses the results of a recent study on the effects...
03/23/2023
Expert Q&A
blood cells
Expert Q&A
Expert Q&A
Dr Tang
Expert Q&A
Expert Q&A
Jordana Cohen
Expert Q&A
Expert Q&A
steven e nissen, md
Expert Q&A
Expert Q&A
jacob
Expert Q&A
Expert Q&A
Expert Q&A
03/01/2023
In this Q and A, Grant Waterer, MBBS, PhD, MBA, answers questions on the recommendations regarding the diagnosis of adults with community-acquired pneumonia, including consideration for inpatient vs...
03/01/2023
Depression Care360
Dr Thomas van Sloten, MD
Depression Care360
Expert Q&A
Expert Q&A
02/27/2023
As the number of new hepatitis C virus infections continues to rise in the United States, rapid diagnosis and treatment of high-risk patients is more important than ever. In this Q&A, Benjamin Eckhardt, MD,...
02/27/2023